Class 4 caution in use-Apixaban 2.5mg and 5mg Tablets

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Apixaban 2.5mg and 5mg Tablets

Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.

MHRA drug alert Date: 26/3/26

MHRA drug alert link:Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17 - GOV.UK

Pip code	Product description	Supplier	Batch Numbers
1258888	Apixaban 5mg Tablets (56)	Sandoz Limited	PS2891 PT0565 PT1417 PU0476 PU0481
1258870	Apixaban 5mg Tablets (28)	Sandoz Limited	PV5375 PW1623 PW1624
1258896	Apixaban 2.5mg Tablets (10)	Sandoz Limited	PT1722
1258904	Apixaban 2.5mg Tablets (20)	Sandoz Limited	PU3287
1258862	Apixaban 2.5mg Tablets (60)	Sandoz Limited	PU1963 PT4596 PT2868 PU2604 PU2605 PU2606

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email mi.uk@sandoz.com, or telephone +44 1276 698101.

For stock control enquiries please email sales.sandoz-gb@sandoz.com, or telephone +44 1276 698020.